Daily Brief United States: Waystar Holding, Shell PLC, American International Group, TotalEnergies, BioStem Technologies , Hawkins Inc, Driven Brands Holdings , Adicet Bio and more

• Waystar Holding (WAY US) is forecasted to pass the mcap and fcap thresholds for the small-cap segment and get added at the November 2024 review.
• The company currently passes the higher regional mcap and fcap thresholds for the small-cap segment at the December 2024 review.
• Waystar Holding (WAY US) risks failing the fcap threshold at the December 2024 review if the stock price falls back to the IPO price levels.

• Shell expects Q3 refining margins to drop 28.6% QoQ to USD 5.5/bbl, driven by a sharp decline in oil prices. However, improved chemical margins are anticipated to offer some relief.
• Between 2023 and 2025, Shell plans to invest USD 10 billion to USD 15 billion in low-carbon solutions globally, with a strategic emphasis on LNG.
• Shell projects LNG to account for 26% of energy sales by 2030, up from 22% in 2023, while oil products will decrease from 48% to 39%.

• The company required a $180 billion bailout from the US government during the financial crisis, but has since fully repaid it with interest.
• Under Peter Zafino’s leadership, AIG has refocused its underwriting efforts, returning to profitability and divesting non-core businesses.
• AIG has undergone a remarkable turnaround post-financial crisis, focusing on specialty insurance for top quartile industry returns

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

• TotalEnergies’ revenue is expected to fall 9.1% QoQ and 17.8% YoY in Q3, while its EPS is expected to rise 6.6% QoQ but fall 19.8% YoY. 
• TotalEnergies anticipates a decline in downstream profitability due to a 65.7% QoQ drop in European refining margins, though increased gas prices are expected to partially offset lower oil prices.
• TotalEnergies raised its annual oil and gas output growth forecast to 3% through 2030. Targets natural gas to comprise 50% of its total sales mix by 2030.

• BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies.
• The company announced testing results for its core BioRetain technology that showed the superiority of the treatment over the traditional standard of care.
• Additionally, the company received national pricing from Medicare for its Vendaje AC product.

• HWKN has grown its water treatment business through acquisition leading to the segment becoming larger than the industrial business. The water treatment segment should become the largest sales generator.
• We believe this growth through inorganic means has resulted in HWKN’s stock trading at a premium to the market and to HWKN’s historic levels. 
• The seasonality the water treatment segment experiences should result in HWKN’s overall gross margin declining in the second half of fiscal 2025. 

• Tigus provides a clear view of industries and companies for research
• Kyle Mowry discusses Driven Brands as a complex but interesting investment
• Driven Brands offers a combination of private equity control and public market liquidity, leading to potential mispricing and alpha opportunity

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

• Adicet Bio is a biotech company working on developing an off-the-shelf CD20 gamma delta CAR-T cell therapy for autoimmune diseases, particularly lupus nephritis
• The company also has gamma delta CAR-T programs targeting various cancers, with value inflection data points expected in 2024 and 2025
• Despite trading at a negative enterprise value, Adicet has significant cash reserves and a manageable quarterly spend, making its equity potentially underpriced compared to peers, with the potential success of its autoimmune program leading to a stock re-rating.

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.